590 related articles for article (PubMed ID: 33107316)
1. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
2. Guillain Barre syndrome associated with COVID-19 infection: A case report.
Sedaghat Z; Karimi N
J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
6. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome after covid-19 infection.
García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
[No Abstract] [Full Text] [Related]
10. Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection.
Naddaf E; Laughlin RS; Klein CJ; Toledano M; Theel ES; Binnicker MJ; Nagappan V; Abdulrazzak M; Phelan DM
Mayo Clin Proc; 2020 Aug; 95(8):1799-1801. PubMed ID: 32753154
[No Abstract] [Full Text] [Related]
11. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
12. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
[No Abstract] [Full Text] [Related]
13. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome associated with SARS-CoV-2 infection.
Velayos Galán A; Del Saz Saucedo P; Peinado Postigo F; Botia Paniagua E
Neurologia (Engl Ed); 2020 May; 35(4):268-269. PubMed ID: 32364123
[No Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome following COVID-19: new infection, old complication?
Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
[No Abstract] [Full Text] [Related]
16. Guillain-Barré syndrome related to COVID-19 infection.
Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
[No Abstract] [Full Text] [Related]
17. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
Rahimi K
Neurol Sci; 2020 Nov; 41(11):3149-3156. PubMed ID: 32876777
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome after COVID-19 in Japan.
Hirayama T; Hongo Y; Kaida K; Kano O
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33122241
[TBL] [Abstract][Full Text] [Related]
19. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
Galassi G; Marchioni A
Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
[TBL] [Abstract][Full Text] [Related]
20. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
